Effects of Folic Acid and Ascorbate Supplementation on Plasma Homocysteine and Oxidative Stress in Patients with Type 2 Diabetes Mellitus.
10.4163/kjn.2009.42.2.107
- Author:
Mi Ri HWANG
1
;
Ju Ryoun SOH
;
Hyeon Sook LIM
Author Information
1. Department of Food & Nutrition, Chonnam National University, Gwangju 500-757, Korea. limhs@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
folate;
ascorbate;
diabetes;
homocysteine;
oxidative stress
- MeSH:
Ascorbic Acid;
Cholesterol;
Diabetes Mellitus, Type 2;
Folic Acid;
Glutathione Peroxidase;
Hemoglobins;
Homocysteine;
Humans;
Lipoproteins, LDL;
Oxidative Stress;
Plasma
- From:The Korean Journal of Nutrition
2009;42(2):107-118
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
In patients with type 2 diabetes, oxidative stress could be increased by their metabolic changes. Elevated plasma homocysteine is considered as one of markers of enhanced oxidative stress. Due to oxidative stress, some complications like cardiovascular or renal diseases may develop in type 2 diabetes patients. Plasma homocysteine concentration may be increased if folate status were inadequate. Protective effects against oxidative stress may be diminished if the status of anti-oxidative nutrient as vitamin C was poor. It is, therefore, important to maintain adequate status of folate and vitamin C in type 2 diabetes patients. Thus, this study was performed to determine the effects of supplementation of folate and/or ascorbate on blood glycated hemoglobin (HbA1c) level, serum concentrations of homocysteine and cholesterol, plasma oxidized low density-lipoprotein (LDL), concentration and plasma glutathione peroxidase (GSH-Px) activity in the patients with type 2 diabetes. A total of 92 type 2 diabetes patients participated voluntarily with written consents. They were divided into one of the four experimental groups; Control (C), Folate-supplemented (F), Ascorbate-supplemented (A), and Folate plus ascorbate-supplemented (FA). The subjects in C were taken placebo, those in F were supplemented 1 mg of folate, those in A received 1,000 mg of ascorbate, and those in FA were given 1 mg of folate plus 1,000 mg of ascorbate daily for 4 weeks. Supplementation of folate or ascorbate resulted to increase serum folate level or plasma ascorbate concentration apparently, respectively. Folate supplementation not ascorbate seemed to decrease plasma concentrations of homocysteine and oxidized LDL and reduce plasma GSH-Px activity. There might not be synergic effect of the supplementation of folate plus ascorbate. The results indicate that oxidative stress in the patients with type 2 diabetes may lower mainly by folate supplementation.
